Treating Emergency Room Opioid Withdrawal with Buprenorphine
|
|
- Natalie Willis
- 5 years ago
- Views:
Transcription
1 Treating Emergency Room Opioid Withdrawal with Buprenorphine Monday, February 11th (3:45pm 4:30pm) Room W314B Christine Bucago, Advanced Practice Clinical Leader (Nursing), CAMH Jane Paterson, Director, Interprofessional Practice, CAMH 1
2 Conflict of Interest Christine Bucago RN, MN, CPMHN(C); Advanced Practice Clinical Leader (Nursing), Acute Care Program AND Jane Paterson, MSW, RSW; Director, Interprofessional Practice Have no real or apparent conflicts of interest to report. 2
3 Agenda Introduction to CAMH Origins Transformation Data-Driven Organization Achievements Buprenorphine Treatment was used 3
4 Learning Objectives Review the clinical benefits of prescribing buprenorphine rather than other medications to ease opioid withdrawal symptoms Outline how to design a clinical workflow, which standardizes how care is delivered to patients in opioid withdrawal visiting an emergency department. Describe how to construct the key elements to embed clinical decision support in the form of a buprenorphine order set to ensure that patients in opioid withdrawal receive the most effective care at the right time 4
5 CAMH Overview 5
6 Location Toronto CAMH is located in downtown Toronto, Canada 6
7 CAMH Transforming Lives Largest mental health and addictions hospital in Canada University of Toronto - affiliated teaching hospital World leader in brain science 3 main sites with 30+ locations 90 distinct clinical services: eg. emergency department, inpatient, outpatient, day treatment, forensic, partial hospitalization programs and other specialty services 7
8 CAMH Clinical Programs Acute Care Complex Care and Recovery (CCR) Child, Youth & Emerging Adult Clinical Services ED (Emergency Department) and Inpatient Services Outreach & Telemedicine Ambulatory Services CCR Inpatient Services CCR Outpatient Services CCR Specialized Services and Research Child, Youth & Emerging Adult Services Clinical Operations Clinical Laboratory and Diagnostic Services Pharmaceutica l Services Medical Services Hospitalist Services Infection Prevention and Control Dental Clinic Podiatry Clinics Dietetic Services Nursing Resource Unit 8
9 CAMH Origins Provincial Lunatic Asylum 9
10 Merger of Founding Organizations 1999 Donwood Institute Clarke Institute of Psychiatry Addiction Research Foundation Queen Street Mental Health Centre 10
11 CAMH Key Statistics Report 11
12 Roadmap to Data-Driven Care Krembil Centre for Neuroinformatics Performance Improvement / Business intelligence Integrated Care Pathways Enterprise Reporting Clinical Information System Transformation Centralized Intake Process IT Infrastructure Optimization 12
13 Why the Davies Award? International recognition that CAMH leverages its clinical information system to support excellence in care delivery and identify ongoing improvement opportunities, in support of our overarching strategic vision. 13
14 Treating Emergency Room Opioid Withdrawal with Buprenorphine 14
15 Agenda Problem Importance Identification / Importance Problem Identification / Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution Selection Solution Selection Interventions Interventions End-User Involvement End-User Involvement Revised Workflow Solution Details Solution Details Effect of Interventions on Data Post- Adherence Data Post- Outcome Data Return on Investment 15
16 Opioid Crisis in Canada Canada is facing a national opioid crisis Over recent years, there has been an alarming increase in the number overdoses and deaths caused by opioids Number (January to September) and estimated annual rate (per 100,000 population) of apparent opioid-related deaths by province or territory, Source: Health Canada. Apparent opioid-related deaths. Retrieved from:
17 Problem Identification Problem Identification CAMH provided Clonidine (comfort measure) as a treatment for individuals presenting to the Emergency Department (ED) with opioid withdrawal There is an additional treatment for opioid withdrawal (buprenorphine) CAMH identified new Health Quality Ontario opioid use disorder standards including: Administration of opioid agonist therapy within 3 days of presentation Opioid agonist therapy should be administered within 2 hours Distribution of take-home naloxone kits Why is this Important? As the leading national academic mental health and addictions hospital, CAMH must lead the way with best-practice treatments Buprenorphine has a ceiling effect and slow action onset, meaning minimal overdose risk Patients on a maintenance dose may have a blunted analgesic and euphoric response if they take other opioids concurrently 17
18 Initial Baseline Workflow Refer to CAMH Medical Withdrawal Service, Addiction Medicine Service, or community non-medical detox Discharge from ED Yes Patient presents to ED with opioid withdrawal Decision to prescribe Clonidine Clonidine order set selected Symptoms relieved? No Continue treatment 18
19 Percentage of Initiations Baseline Data 2015 Q Q3 Clonidine Initiations 20.8% Buprenorphine Initiations 8.5% 50% Percentage of Initiations for Opioid Withdrawal Patients 40% 30% 20% 10% 0% 2015 Q Q Q Q3 Calendar Quarter Suboxone Initiations Clonidine Initiations 19
20 Objectives Standardize pathway and treatment protocol for buprenorphine Create barrier-free and timely access to continuing care Streamline ordering process to save clinician time and prevent errors Adhere to new Health Quality Ontario standards for opioid withdrawal and opioid use disorder 20
21 Solution Selection CAMH identified a method to ensure increased use of buprenorphine within the ED. Options reviewed and selected by CAMH Addiction Medicine Service and ED management with staff consultation: -Experience with other order sets showed positive practice change Clinician familiarity Dynamic reporting Communicatio n tools Existing change management Tracking and feedback Standardized practice Existing governance Standardized documentation 21
22 Interventions Addiction Medicine Service Partnership Education Sessions Order Set And Pathway Partnership between CAMH Addiction Medicine Service and Emergency Department to build capacity for addictions treatments, including buprenorphine (Nov 2016 Mar 2017) Education sessions including benefits, initiation, and administration of buprenorphine for all ED staff (May June 2017) Creation of an interdisciplinary buprenorphine pathway and buprenorphine order set (August 2017 go-live) 22
23 Strategic Governance High-level Decisions Executive Leadership Team CEO Medical Advisory Committee Physician in Chief Mid-Level Decisions Pharmacy & Therapeutics Dir. Pharmacy Health Information Interdisciplinary Committee Dir. Interprof. Practice Dir. Medical Informatics Clinical Care Committee Dir. Interprofessional Practice Chief Medical Officer Order Sets Sub-Committee Dir. Medical Informatics Pharmacist Physician / Hospitalist User Groups Dir. Medical Informatics Lead Hospitalist Practice Adoption & Optimization Council Manager, Clinical Education Advanced Practice Clinical Lead Collaborative Practice Advisory Committee Chief of Nursing Data and Reporting Governance Committee (ELT Sub-Committee) Exec. Dir. Performance Improvement Med. Dir. Performance Improvement Clinical Applications Change Advisory Board Sr. Manager, Clinical Applications Integrated Health Record Council Dir. Clinical Information Systems APPROVED ** Advisory / Working Groups established as required 23
24 End-User Involvement Integrated Health Record Committee Chairs: Dir. Interprofessional Practice, Dir. Medical Informatics Includes clinicians and other stakeholders Initial approval of need Pharmacy & Therapeutics Co-chairs: Appointed Physician and Dir. Pharmacy Owners and approvers of Order Set Includes a minimum of 6 physicians, 4 pharmacists Order Sets Sub-Committee Chairs: Dir. Medical Informatics, Pharmacist Assembled subject matter clinical experts for review of order sets Medical Advisory Committee Chair: Physician in Chief High-level review and recommendations regarding the practice of medicine at CAMH 24
25 Revised Workflow Patient presents to ED with opioid withdrawal Re-assess in 2 hours Administer additional dose No No Does patient agree to buprenorphine treatment? Yes Buprenorphine induction order set selected* Clinical Opiate Withdrawal Scale completed * Result >12? * Yes Administer buprenorphine* Reassess in 2 hours * Symptoms relieved? No Yes Proceed with Clonidine or alternative treatment Discharge from ED Refer to CAMH Addiction Medicine Service, prescribe total daily dose, provide Naloxone kit and information * Total daily dose established Health IT used within intervention*
26 Suboxone Order Set Clinical Opiate Withdrawal Scale Administration guidelines Buprenorphine Order Set Standardized Lab orders Vital signs Clinical Opiate Withdrawal Scale Rapid Access Referral Distribution of Naloxone kits Patient education materials Rapid Access Referral Free Naloxone kit flyer Dosage options 26
27 Clinical Opiate Withdrawal Scale (COWS) COWS Used in ED for patients presenting with opiate withdrawal symptoms Recommended for use during buprenorphine induction <2 minutes for completion Automated scoring Key 27
28 Rapid Access Referral Rapid access autopopulates 28
29 Outcomes Intervention Effect of Interventions on Data AMS Partnership Education Sessions Order Set and Pathway Partnership between CAMH Addiction Medicine Service and Emergency Department to build capacity for addictions treatments, including buprenorphine (Nov 2016 Mar 2017) Education sessions including benefits, initiation, and administration of buprenorphine for all ED staff (May June 2017) Creation of an interdisciplinary buprenorphine pathway and buprenorphine order set (August 2017 go-live) Created clinical awareness Generated familiarity and comfort with prescribing opioid agonist therapy Created practice guidelines to educate staff about buprenorphine and its use within opioid withdrawal and maintenance therapy Created clinical awareness and enforced regulations to standardize practice for buprenorphine patients Provided rapid access referral option to support evidencebased practice 29
30 Percentage of Initiations Post- Adherence Data 2015 Q Q Q Q2 Clonidine Initiations 20.8% 8.5% Buprenorphine Initiations 8.5% 28.4% 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% Percentage of Initiations for Opioid Withdrawal Patients AMS Partnership Education Order Set Pre-implementation Post-implementation 2015 Q Q Q Q Q Q Q Q Q Q Q2 Calendar Quarter Suboxone Initiations Clonidine Initiations
31 Repeat Visits Post- Outcome Data 2015 Q Q Q Q2 Repeat ED Visits within 7 days 5.31% 3.96% 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% 5.1% 5.0% Repeat ED Visits for Opioid Withdrawal Patients Pre-implementation 3.1% 7.9% AMS Partnership 5.5% 12.9% 2015 Q Q Q Q Q Q Q Q Q Q Q2 Calendar Quarter Education 3.0% Order Set 6.8% Post-implementation 3.0% 0.0% 4.8% Repeat ED Visits Within 7 Days
32 Average Wait Time (Days) Post- Outcome Data Average wait time between ED and CAMH AMS rapid access service for Opioid Withdrawal patients Q Q Q Q2 32
33 Return on Investment Cost of Treating Patients Presenting in ED with an Opioid Diagnosis who were Admitted to Inpatient Pre Order Set & Rapid Access Referral (August 1, July 31, 2017) Savings = $137,462 $628,028 $490,566 Post Order Set & Rapid Access Referral (August 1, July 31, 2018) Twenty-four fewer patients with opioid withdrawal diagnoses were admitted to inpatient after improvements in care due to buprenorphine initiations. (Cost of ED visit * # ED visits) + (# admitted to IP * LOS * IP day cost) 33
34 Return on Investment Able to treat opioid withdrawal onsite in a safe and effective manner Adhere to Health Quality Ontario guidelines for opioid agonist therapy Reduce repeat ED visit rates for opioid withdrawal patients presenting to ED 34
35 Lessons Learned Streamlining the ordering process has been beneficial to clinicians while emergency volumes increase Ongoing efforts are required to ensure residents and clinicians are confident initiating treatments Buprenorphine is the most supported treatment through research, but other medications are appropriate for some patients 35
36 Questions Christine Bucago, Advanced Practice Clinical Leader (Nursing) Jane Paterson, Director, Interprofessional Practice, CAMH Please ensure to complete the online survey for this session: 36
Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH
2 Buprenorphine Order Set and Rapid Access Referral 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution
More informationMonitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH
1 Monitoring Protocol for Clozapine-induced Myocarditis 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives
More informationAddressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention
The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:
More informationAddiction Services in the Central West LHIN
Addiction Services in the Central West LHIN Helen Danakas Coordinator, Withdrawal Management Hélène (Leela Leela) Tanguay, PhD, RP, ICADC Coordinator, Narcotics Strategy Overview of Presentation Addiction
More informationWhat is the strategy?
What is the strategy? Multi-pronged approaches to reducing the health consequences of opioid use, New York City Northeast Epidemiology Conference Public health approach Track drug use and associated health
More informationONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health
ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE Dr. David Williams Chief Medical Officer of Health National opioid-related mortality data, 2016 (Health Canada) Provincial Overdose Coordinator
More informationRecommendations for Components of Emergency Department Discharge Protocols
Recommendations for Components of Emergency Department Discharge Protocols Background Maryland, like many other states, is in the midst of an opioid crisis. In 2016, 89 percent of all intoxication deaths
More informationONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE
ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE Sean Court Director, Strategic Policy Branch Ministry of Health and Long-Term Care November 24, 2017 Strategy to Prevent Opioid Addiction and
More informationClosing the Loop in Treating Opioid Addiction:
Closing the Loop in Treating Opioid Addiction: Integrating MAT into Prison and Jail Health Systems May 9, 2018 Webinar Housekeeping All lines are muted This session will be recorded To ask a question:
More informationOpioid Stewardship Davies Presentation
Opioid Stewardship Davies Presentation Todd Burstain, MD CMIO Ochsner Health Systems Deborah Simonson, Pharm D. Vice President, Pharmacy Ochsner Health Systems Richard Guthrie, MD Chief Quality Officer
More informationMinistry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference
Ministry of Health and Long-Term Care Presentation to the CPSO Methadone Prescribers Conference November 9, 2012 Overview Minister s Expert Working Group on Narcotic Addiction OxyNEO and OxyContin: Changes
More informationHospitals Role in Addressing the Opioid Crisis
Hospitals Role in Addressing the Opioid Crisis Webinar 4: Overdose Survivors Outreach Project October 18, 2017 Agenda Overdose Survivors Outreach Project (OSOP) Background Barry Page, Director of Early
More informationFentanyl, Opioid Overdose and Naloxone
Fentanyl, Opioid Overdose and Naloxone Opioid Agonist Therapy Conference Saskatoon, SK April, 2016 Declaration No conflict of interest. Consultant in Addiction Medicine, SHR. Chair, College of Physicians
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationTREATING OPIOID ADDICTION IN HOMELESS POPULATIONS
TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health
More informationSpring 2011: Central East LHIN Options paper developed
Glenna Raymond, Chair, RSGS Governance Authority Victoria van Hemert, RSGS Executive Director 1 Spring 2011: Central East LHIN Options paper developed Called for new entity to oversee and improve the coordination
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More informationAgenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model
Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased
More informationAddressing the Opioid Crisis An ACH Collaboration
Addressing the Opioid Crisis An ACH Collaboration The purpose of this document is to offer a set of strategies that can help hospitals, health systems, and independent/group practices and Accountable Communities
More information2018/ /21 SERVICE PLAN
Ministry of Mental Health and Addictions 2018/19 2020/21 SERVICE PLAN February 2018 For more information on the Ministry of Mental Health and Addictions contact: Ministry of Mental Health and Addictions
More informationHospitals Role in Addressing the Opioid Crisis
Hospitals Role in Addressing the Opioid Crisis Webinar 5: Buprenorphine in the Emergency Department November 14, 2017 Agenda Hospital Based Buprenorphine Initiatives Yngvild Olsen, M.D., Medical Consultant,
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationAn Evaluation of the Bruce Grey Hospital-Community Smoking Cessation Program
May, 2011 An Evaluation of the Bruce Grey Hospital-Community Smoking Cessation Program Prepared for Keystone Child, Youth and Family Services & Partners By The Centre for Community Based Research www.communitybasedresearch.ca
More informationHL3.01 REPORT FOR ACTION. Toronto Indigenous Overdose Strategy SUMMARY
HL3.01 REPORT FOR ACTION Toronto Indigenous Overdose Strategy Date: February 6, 2019 To: Board of Health From: Medical Officer of Health Wards: All SUMMARY The opioid poisoning crisis continues unabated
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationTable of Contents Interim Report of the OxyContin Task Force, Newfoundland & Labrador, January 30, 2004
OXYCONTIN TASK FORCE INTERIM REPORT January 30, 2004 Submitted to Hon. Elizabeth Marshall, Minister of Health & Community Services, Government of Newfoundland and Labrador Table of Contents INTRODUCTION
More informationCommunity Opioid Load: Concept to Action in Kingston-KFLA
Community Opioid Load: Concept to Action in Kingston-KFLA Dr Kieran Moore CCFP (EM ) FCFP FRCPC MPH MSc (DM ) Professor of Emergency and Family Medicine Associate Medical Officer of Health, KFLA, Program
More information5 HEALTH PRIORITIES, 10 OUTCOME MEASURES
Community Health Needs Assessment 217-219 5 HEALTH PRIORITIES, 1 OUTCOME MEASURES improving the health of our community in all we do 217 progress Report 217 218 219 ased on a comprehensive community needs
More informationCOMMITMENT TO A TOBACCO ENDGAME IN ONTARIO
COMMITMENT TO A TOBACCO ENDGAME IN ONTARIO Our Ask That the Ontario government: Renew their commitment to achieving the lowest smoking rate in Canada Align the Smoke Free Ontario Strategy with the proposed
More informationMedicaid and the Opioid Crisis
Medicaid and the Opioid Crisis Erica Floyd Thomas Bureau Chief of Medicaid Policy Agency for Health Care Administration Presented to: Medical Care Advisory Committee March 20, 2018 1 Florida Medicaid Covers
More informationLinking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
More informationTaos Alive. Improving a Community in Pain By Julie Martinez CPS
Taos Alive Improving a Community in Pain By Julie Martinez CPS About Taos County About Taos Alive Community Based Coalition 12 Sectors (Youth, Parents, Business, Media, Schools, Youth Serving Organizations,
More information8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door
California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives Gloria Miele, PhD, Learning Collaborative Coordinator, Hub and Spoke MAT Expansion Project Richard Rawson, PhD, Professor
More informationPublic Health Unit Tobacco Use Cessation Services
March 2017 Public Health Unit Tobacco Use Cessation Services Under the Ontario Public Health Standards, 1 Public Health Units (PHUs) are required to do a number of activities related to tobacco use cessation
More informationTITLE AUTHORS. Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy
TITLE Naloxone Counseling for Harm Reduction and Patient Engagement AUTHORS Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy Marianne E. Koenig, PharmD UPMC St. Margaret Family
More informationFOR IMMEDIATE RELEASE MARCH
FOR IMMEDIATE RELEASE MARCH 20, 2018 Contact: Jeff Washington, Deputy Executive Director, ACA, Alexandria, VA jeffw@aca.org 703-224-0103 Contact: Bob Davis, VP, Marketing, Membership & Engagement, ASAM,
More informationWORKING UPSTREAM TO COMBAT THE OPIOID CRISIS
WORKING UPSTREAM TO COMBAT THE OPIOID CRISIS WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association PRESENTER Sarah Derr, PharmD Medication Management Lead Iowa Healthcare
More informationBuilding capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
More informationSustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care. Presenter: Malinda Boehler, MSW, LCSW 15 March 2017
Sustaining Integrated Care: Making the Business Case for Routine HIV Screening and Care Presenter: Malinda Boehler, MSW, LCSW 15 March 2017 Routine HIV Screening in Community Health Centers: Making the
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationMANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling
MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin
More informationBuprenorphine Prescribing as a Patient- Centered Medical Home Enhancement
Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE
More informationFighting Today s Opioid Epidemic
Fighting Today s Opioid Epidemic Establish in 1966 as a Public Health Department Location: Rock Falls, IL/Whiteside County Population: Whiteside County 2015--57,079 Serving Rural IL: Primarily Whiteside,
More informationOpioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative
Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative Objectives Summarize the current crisis at the national and Iowa state level.
More informationStrategic Plan: Implementation Work Plan
Healthy Eating Active Living New Hampshire Strategic Plan: Implementation Work Plan July 1, 2011 June 30, Adopted: July 28, 2011 Goal One: Increase the number and effectiveness of community coalitions
More informationRI Centers of Excellence for the
RI Centers of Excellence for the Treatment of Opioid Use Disorder COE CODAC Behavioral Healthcare Linda Hurley President/CEO 9-18-17 for the Warren Alpert Medical School of Brown University RI s Strategic
More informationHL18.3 REPORT FOR ACTION. Toronto Overdose Action Plan: Prevention & Response SUMMARY
HL18.3 REPORT FOR ACTION Toronto Overdose Action Plan: Prevention & Response Date: March 10, 2017 To: Board of Health From: Acting Medical Officer of Health Wards: All SUMMARY At its meeting of December
More informationOpioid Prescribing Improvement Program
Opioid Prescribing Improvement Program Jeff Schiff, MD, MBA, Medical Director of Minnesota Health Care Programs Sarah Rinn, MPH, Opioid Prescribing Improvement Program Coordinator Agenda Opioid Prescribing
More informationImproving Opioid Agonist Therapies with System Change
Improving Opioid Agonist Therapies with System Change DENNIS MCCARTY OHSU- PSU SCHOOL OF PUBLIC HEALTH OREGON HEALTH & SCIENCE UNIVERSITY PORTLAND, OR 97239 BOOST LAUNCH VANCOUVER, BC SEPTEMBER 15, 2017
More informationS 0332 S T A T E O F R H O D E I S L A N D
LC00 01 -- S 0 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO HEALTH AND SAFETY - COMPREHENSIVE DISCHARGE PLANNING Introduced By: Senators Miller,
More informationRevised 9/30/2016. Primary Care Provider Pain Management Toolkit
Revised 9/30/2016 Primary Care Provider Pain Management Toolkit TABLE OF CONTENTS 1. INTRODUCTION Page 1 2. NON-OPIOID SERVICES &TREATMENTS FOR CHRONIC PAIN Page 2 2.1 Medical Services Page 2 2.2 Behavioral
More informationPharmacy Partnership to Improve Patient Outcomes
Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners
More informationEarly Intervention with Youth. Leanne Paisley Addiction Counsellor The Royal Ottawa Mental Health Centre January 27, 2014
Early Intervention with Youth Leanne Paisley Addiction Counsellor The Royal Ottawa Mental Health Centre January 27, 2014 Me! What more to know Expectations for today Participation ROIS = Regional Opioid
More informationCentral East LHIN Self-Management Program
Central East LHIN Self-Management Program Central East LHIN Board Meeting February 22, 2017 Trish Topping, Senior Manager, Central East LHIN Self-Management Program Kasia Luebke, Lead Central East LHIN
More informationNorth Simcoe Muskoka Specialized Geriatric Services Program ACCOUNTABILITY & AUTHORITY FRAMEWORK
North Simcoe Muskoka Specialized Geriatric Services Program ACCOUNTABILITY & AUTHORITY FRAMEWORK February 4, 2016 March 31, 2018 SPECIALIZED GERIATRIC SERVICES PROGRAM ACCOUNTABILITY & AUTHORITY FRAMEWORK
More informationREGIONAL SPECIALIZED GERIATRIC SERVICES GOVERNANCE AUTHORITY. Call for Expressions of Interest from Seniors Advocate/Public Member
REGIONAL SPECIALIZED GERIATRIC SERVICES GOVERNANCE AUTHORITY Call for Expressions of Interest from Seniors Advocate/Public Member A. BACKGROUND Specialized Geriatric Services (SGS) provide a range of services
More informationThe Coordinated Implementation of Pallium Canada s LEAP Curriculum in Nova Scotia. Beth R. Tupala, RN, CHPCN(C) Cheryl Tschupruk, M.S.W., R.S.W.
The Coordinated Implementation of Pallium Canada s LEAP Curriculum in Nova Scotia Beth R. Tupala, RN, CHPCN(C) Cheryl Tschupruk, M.S.W., R.S.W. Today s Objectives Provincial Objectives Context Process
More informationThe Center for Outreach and Community Care
The Center for Outreach and Community Care Annual Report 2013-2014 P r e p a r e d b y : C h i l d a n d Y o u t h C a r e A p r i l 2 0 1 4 TABLE OF CONTENTS EXECUTIVE SUMMARY 2 i History of the Outreach
More informationInjectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP
Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Overview Gavin Foundation Injectable naltrexone Community report
More informationVeterans Health Administration Pharmacy Benefits Management Academic Detailing Services
Veterans Health Administration Pharmacy Benefits Management Academic Detailing Services Melissa Christopher, Pharm.D. National Director, Academic Detailing Services VACO PBM San Diego, California USA Academic
More informationVIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC
1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug
More informationBuilding a New Approach to Health Care Services for Hard to Reach Clients
Building a New Approach to Health Care Services for Hard to Reach Clients Community Discussion and Open House January 30, 2013 Fernwood Community Association 1923 Fernwood Street February 6, 2013 North
More informationSouth Belfast Integrated Care Partnership. Transforming Delivery of Diabetes Care 2014
South Belfast Integrated Care Partnership Transforming Delivery of Diabetes Care 2014 Background Context: Aims: Reduction in T2DM Earlier recognition of Type 1 diabetes in children Reduction in risk and
More informationMELISSA STAHL SENIOR RESEARCH MANAGER THE HEALTH MANAGEMENT ACADEMY
CASE STUDY MANAGING THE OPIOID EPIDEMIC: FAIRVIEW HEALTH SERVICES The Academy The Health Management Academy MELISSA STAHL SENIOR RESEARCH MANAGER THE HEALTH MANAGEMENT ACADEMY INTRODUCTION THE OPIOID EPIDEMIC
More informationInterprofessional Education in Palliative and End-of-Life Care for Oncology (iepec-o)
Interprofessional Education in Palliative and COURSE SYLLABUS iepec-o development was led by: Susan Blacker, MSW, RSW Paul Daeninck, MD, MSc, FRCPC Judy Simpson, RN, BN, MEd, CHPCN(C) Course Offering:
More informationAetna s Initiative on the Opioid Epidemic
Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than
More informationIntegrating Primary Care for Addiction Treatment
A23 These presenters have nothing to disclose Integrating Primary Care for Addiction Treatment By Donna Gallbreath, MD Senior Medical Director and Melissa Merrick, LCSW, CDCI Clinical Director of Behavioral
More informationOpioid Crisis, Our Response Massachusetts Coalition for the Prevention of Medical Errors. October 31, 2016
Opioid Crisis, Our Response Massachusetts Coalition for the Prevention of Medical Errors October 31, 2016 Introduction: The Team Dr. Tony Dodek, Vice President, Medical Quality & Strategy, and Associate
More informationOntario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario
Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those
More informationRegional Clinical Co-Lead (Physician) Role Opportunity
Regional Clinical Co-Lead (Physician) Role Opportunity The South West Hospice Palliative Care Network (SWHPCN) in partnership with the South West LHIN and the South West Regional Cancer Program are seeking
More informationECCA Page 1
University of Michigan Hospitals and Health Centers UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS Delineation of Privileges Department of Internal Medicine Division of Geriatric and Palliative Medicine
More informationBuilding a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine
Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Scott M. Gagnon, MPP, PS-C Director, AdCare Educational Institute of Maine, Inc. Co-Chair, Prevention & Harm
More information7/7/2016 Journal of the American Medical Association,
1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of
More informationControlled Substances: A survey of tools and resources required by hospital pharmacists
Controlled Substances: A survey of tools and resources required by hospital pharmacists TABLE OF CONTENTS 2018. Canadian Society of Hospital Pharmacists About the survey 1 The Short and Snappy 1 What CSHP
More informationFrom Data to Optimized Healthcare Outcomes: Using Prescriptive Analytics to Maximize Patient Access, Costs and Quality of Care
From Data to Optimized Healthcare Outcomes: Using Prescriptive Analytics to Maximize Patient Access, Costs and Quality of Care CGI Group Inc. 2014 Outline About Jewish General Hospital, Montreal & Their
More informationIMPACT APA STRATEGIC PLAN
IMPACT APA STRATEGIC PLAN I am very proud to be a psychologist. Most in psychology chose this field for the pursuit of knowledge and to make an impact, and I ve seen firsthand how psychology affects practically
More informationProvincial Health Services Authority. Correctional Health Services - Update. Dr. Nader Sharifi Andrew MacFarlane. April 11/2018
Provincial Health Services Authority Correctional Health Services - Update Dr. Nader Sharifi Andrew MacFarlane April 11/2018 Similar to FNHA, PHSA covers the entire province of BC Correctional Health Services
More informationPrescription Opioid Overdose in Oregon: A public health perspective
Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,
More informationMinistry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW
Chapter 1 Section 1.08 Ministry of Health and Long-Term Care Palliative Care Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of Actions Recommended Actions
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationRE: PROPOSED AMENDMENTS TO REGULATIONS TO THE CONTROLLED DRUGS AND SUBSTANCES ACT
November 8, 2017 Ms. Michelle Boudreau Director General Controlled Substances Directorate Office of Legislative and Regulatory Affairs Health Canada 150 Tunney s Pasture Driveway, Main Stats Building Address
More informationCanada Regional Call. Monday, November 12, 2018
Canada Regional Call Monday, November 12, 2018 WebEx Quick Reference Welcome to today s session! Please use chat to All Participants for questions For technology issues only, please chat to Host WebEx
More informationDEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014
DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 Karen Arts, Director Canadian Cancer Clinical Trial Network (3CTN) Chair of the Board of N2 Administrative Office: Lawson
More informationThe Opioid Addiction Crisis in the Northern Shenandoah Valley. A Community Response
The Opioid Addiction Crisis in the Northern Shenandoah Valley A Community Response 1 Overview of the Problem Objectives Formation of the Northern Shenandoah Valley Substance Abuse Coalition Roles of key
More informationStrategic overview of sexual health procurement Haringey and London
Strategic overview of sexual health procurement Haringey and London Sarah Hart : March 2017 2 Context for redesign of sexual health services in Haringey and London From July 2017 there will be a new offer
More informationCHILD ENDS HERE HOMELESSNESS. 3 Year Strategic Plan Inn from the Cold 3 Year Strategic Plan
CHILD HOMELESSNESS ENDS HERE 3 Year Strategic Plan 2018-2021 a LET S HELP CHILDREN MORE Over the last 20 years, the Inn on our shelter, sanctuary and healing has grown from a grassroots organization to
More informationStrategic Plan
2017-18 Strategic Plan 1 Strategic Planning Process The Summit County Opiate Task Force has made great strides in addressing the opiate crisis in the last few years. More than 100 Summit County citizens
More informationSubject: Recommendation:
Subject: Purpose: Recommendation: Integrated Joint Board 15th November 2018 North Ayrshire Alcohol And Drug Partnership (ADP) Annual Report 2017-18 To present the Alcohol and Drug Partnership s Annual
More informationOpioid Treatment Program Reimbursement Re-bundling Proposal
Opioid Treatment Program Reimbursement Re-bundling Proposal Maryland Department of Health and Mental Hygiene April 22, 2016 The Department reviewed close to 50 letters and emails submitted by stakeholders
More informationPeer Naloxone. A harm reduction approach to overdose prevention. Kristel Guthrie RN BScN BA. Chantel Marshall RN BScN. The Works Toronto Public Health
Peer Naloxone A harm reduction approach to overdose prevention Kristel Guthrie RN BScN BA Chantel Marshall RN BScN The Works Toronto Public Health November, 2011 Overview of Session Timeline of >POINT
More informationImproving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership
Improving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership Lena Asmar, MSW, LICSW Director, Veteran 360 Behavioral Health Programs, New England Center and Home for Veterans
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationEXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS
EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we
More informationThe Opioid Addiction Crisis in the Northern Shenandoah Valley. A Community Response
The Opioid Addiction Crisis in the Northern Shenandoah Valley A Community Response 1 Overview of the Problem Objectives Formation of the Northern Shenandoah Valley Substance Abuse Coalition Roles of key
More informationFull Name of Training Program TEACH: Training Enhancement in Applied Cessation Counselling and Health
ATTUD APPLICATION FORM FOR WEBSITE LISTING (PHASE 1): TOBACCO TREATMENT SPECIALIST (TTS) TRAINING PROGRAM APPLICATION NUMBER: TTS 2008_5_ 0003 PROGRAM INFORMATION & OVERVIEW Date of this Application May
More informationSubstitution Therapy for Opioid Use Disorder The Role of Suboxone
Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationPrimary Health Networks
Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-17 to 2018-19 Hunter New England & Central Coast Please note: This Activity Work Plan was developed in response to the HNECC PHN
More informationBehavioral Health Integration in the Mount Sinai Health System: Opioid Treatment and Primary Care
Behavioral Health Integration in the Mount Sinai Health System: Opioid Treatment and Primary Care HANYS Behavioral Health SWAT October 4, 2017 Sabina Lim MD, MPH Vice President and Chief of Strategy, Behavioral
More informationImproving the Quality of Addiction Treatment
Improving the Quality of Addiction Treatment Expanding Access to Medication-Assisted Treatment in Residential Addiction Treatment Programs Webinar sponsored by RTI International January 18, 2018 RTI International
More information